Dr. Bhavna Rani is an accomplished molecular and cell biologist with over a decade of research experience spanning academia and industry across Europe. Her work focuses on cancer biology, stem cells, and cell signaling, employing advanced techniques such as 10X CITE-seq, click chemistry, and high-resolution imaging. She has held postdoctoral positions at prestigious institutions including Uppsala University and the Karolinska Institute, contributing to high-impact research and authoring numerous peer-reviewed publications. Dr. Rani is also actively involved in teaching and mentoring at both master’s and doctoral levels and has received research grants and recognition for her scientific contributions. Her multidisciplinary expertise includes project management, business innovation, and sustainability practices gained through academic-industry collaborations. Fluent in English and proficient in Swedish, she demonstrates strong communication and leadership skills through her roles in scientific committees and postdoctoral associations. Driven by innovation and collaboration, Dr. Rani is committed to advancing biomedical research and its translational applications.
ORCID Profile
Dr. Bhavna Rani holds a Marie Curie-funded Ph.D. in Surgical and Experimental Sciences and Cellular Therapies from the University of Bari, Italy, where she conducted translational cancer research focusing on TGF-beta inhibitors in hepatocellular carcinoma. Prior to that, she completed a top-tier Master’s program (M.Sc.) in Oncology from Vrije University, Amsterdam, Netherlands, gaining a solid foundation in cancer biology and experimental therapeutics. She also holds additional certifications in Intellectual Property Law, Research Ethics, Leadership, Sustainability, and Health Policy from prestigious institutions like Uppsala University and Karolinska Institute. These certifications reflect her commitment to continuous learning and her interdisciplinary approach to research. Her diverse educational background across multiple countries has provided her with strong analytical, theoretical, and ethical frameworks, making her well-equipped for advanced scientific research and academic leadership. This comprehensive education forms the backbone of her successful career in molecular biology and translational research.
Dr. Bhavna Rani has amassed extensive research experience across leading European institutions. She is currently a researcher at Uppsala University, where she works on centrosome clustering and cancer therapeutics. Previously, she was a postdoctoral researcher at the Karolinska Institute, focusing on integrin signaling in stem cells using 10X CITE-seq and advanced 3D culture models. Her career includes multiple postdoctoral roles in Sweden, Italy, Germany, and Spain, covering areas such as MEK therapy resistance in pancreatic cancer and tumor microenvironment imaging using MRI techniques. She has also gained biotech industry experience during her internship at Key2Brain AB, contributing to Alzheimer’s disease models and sustainability protocols. Additionally, she has been involved in scientific advisory roles, market analysis, and mentoring master’s students. Her professional journey highlights her interdisciplinary expertise, international collaborations, and ability to navigate both academic and industrial research environments effectively.
Dr. Bhavna Rani’s research interests lie at the intersection of molecular cell biology, cancer therapeutics, and regenerative medicine. She is particularly focused on understanding the mechanisms of cytokinesis, centrosome clustering, and cell adhesion in both normal and cancerous cells. Her work extends into integrin-mediated signaling, stem cell biology, and the tumor microenvironment, utilizing tools such as 10X CITE-seq, click chemistry, and 3D scaffolds. She is passionate about translating basic cellular mechanisms into therapeutic strategies, especially in targeting cancer stemness, drug resistance, and abnormal cell division. Her interest in translational science is also evident in her past research on liver regeneration and MEK resistance pathways, as well as her involvement in preclinical studies on Alzheimer’s disease. Through a combination of molecular techniques, imaging, and biomaterial sciences, Dr. Rani aims to develop targeted interventions that improve disease outcomes and patient care in oncology and regenerative medicine.
Dr. Bhavna Rani has received notable recognition throughout her academic and research career. She was a prestigious Marie Curie Fellow during her Ph.D., an award reserved for top-tier researchers in the EU. Her research has been funded by competitive grants such as the A&M Rudberg and Marcus and Amalia Wallenberg Foundation, acknowledging the impact and promise of her scientific contributions. She has served as a reviewer for peer-reviewed journals like Cancer Medicine, further establishing her authority in the biomedical field. Additionally, she has been an active member of scientific societies, including the European Association for the Study of the Liver (EASL) and the European Society for Clinical Investigation (ESCI). She also held leadership roles in postdoctoral associations at Uppsala University and Karolinska Institute. While her list of named awards could expand, her consistent record of grants, fellowships, and leadership roles reflect strong academic recognition.